Moderna considering $110-$130 for COVID shot, similar to Pfizer’s, WSJ says

Moderna (MRNA) is considering a commercial price in a range of $110 to $130 per dose in the U.S. for its COVID-19 vaccine when it shifts from government contracting to commercial distribution, reported The Wall Street Journal. This range is similar to the one Pfizer (PFE) said in October it was considering for the COVID-19 vaccine it developed with BioNTech SE (BNTX) noted the report from Peter Loftus, who cites comments from Moderna’s CEO. "I would think this type of pricing is consistent with the value [of the vaccine]," Loftus quotes Moderna CEO Stephane Bancel as having said in an interview on the sidelines of the J.P. Morgan Healthcare Conference. Reference Link